341 related articles for article (PubMed ID: 17511031)
1. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
3. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
Xin XM; Li GQ; Jin YY; Zhuang M; Li D
World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
He YW; Guo CX; Pan YF; Peng C; Weng ZH
World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
[TBL] [Abstract][Full Text] [Related]
8. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ
World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Zhou YB; Wang YF; Zhang Y; Zheng LY; Yang XA; Wang N; Jiang JH; Ma F; Yin DT; Sun CY; Wang QD
Eur J Pharmacol; 2012 May; 683(1-3):10-5. PubMed ID: 22387093
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
12. Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.
Xu WZ; Fang Y; Li D; Wang Y; Shang QL; Li GQ; Teng X; Gu HX
World J Gastroenterol; 2008 Jun; 14(23):3733-8. PubMed ID: 18595141
[TBL] [Abstract][Full Text] [Related]
13. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.
Parvez MK; Sehgal D; Sarin SK; Basir SF; Jameel S
World J Gastroenterol; 2006 May; 12(19):3006-14. PubMed ID: 16718779
[TBL] [Abstract][Full Text] [Related]
15. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
[TBL] [Abstract][Full Text] [Related]
16. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
17. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
[TBL] [Abstract][Full Text] [Related]
19. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]